Cellectar Biosciences (CLRB) Other Non Operating Income (2013)
Cellectar Biosciences (CLRB) posted Other Non Operating Income of -$744957.0 for Q4 2013.
Cellectar Biosciences (CLRB) Other Non Operating Income (2013) Analysis & Trends
Cellectar Biosciences has reported Other Non Operating Income for 1 years, with the latest figure at -$744957.0 in Q4 2013.
- Quarterly Other Non Operating Income changed N/A year-over-year to -$744957.0 in Q4 2013, while the trailing twelve-month figure through Sep 2014 was -$744957.0 (changed N/A YoY) and the FY2025 annual result came in at $4000.0, down 99.51% from the prior year.
- Other Non Operating Income held at -$744957.0 in Q4 2013 per CLRB's latest filing.
- Over five years, Other Non Operating Income peaked at -$744957.0 in Q4 2013 and troughed at -$744957.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cellectar Biosciences | 6.73 Mn | 6.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -744,957.00 |